Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Health Care M&A Deals, July 31, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is a global development and commercialization agreement for DS-1062 between AstraZeneca plc and Daiichi Sankyo Company valued at $1 billion. DS-1062 is Daiichi Sankyo’s proprietary trophoblast cell-surface antigen 2 (TROP2)-directed antibody-drug conjugate (ADC), and potential new medicine for the treatment of multiple tumor types. The companies will... Read More »
Health Care M&A Deals, July 24, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week was Dedalus Group’s acquisition of DXC’s healthcare software provider business for $525 million. To subscribe to our Health Care M&A deals chart and more, visit our membership site. HealthCareMandA.com is devoted to healthcare merger and acquisition data for the serious analyst and investor. Every day, this service alerts you to... Read More »
GI Alliance Expands Market Reach in Illinois
GI Alliance announced two new acquisitions in Illinois last week. With the backing of private equity firm Waud Capital Partners, the company has expanded nationwide quickly, announcing nearly 10 transactions since early 2019, according to DSO. And GI Alliance doesn’t seem to be slowing down, even in the midst of a pandemic that is forcing other providers to hit pause on M&A transactions. First, GI Alliance has acquired the Illinois Gastroenterology Institute (IGI). Founded in 1987, IGI serves adult patients throughout downstate Illinois, with many physicians sub-specializing in various aspects of gastroenterology. The practice has nine physicians. and its main office is on the... Read More »
DXC Divests Another Business Line
DXC Technology (NYSE: DXC) has spent 2020 trying to streamline its business portfolio. When Mike Salvino took over as CEO of DXC in September 2019, he announced during his first earnings call that the company was planning strategic alternatives, including the possible divestiture of three of its non-core assets, which made up roughly 25% of the company’s revenue. And last week, DXC announced another milestone in that campaign. The company revealed it is selling its healthcare software provider business to Dedalus Group for $525 million. DXC’s healthcare software business is an open digital health platform that helps improve care outcomes by delivering contextual and... Read More »
AstraZeneca Strikes Another Collaboration with Daichi Sankyo
AstraZeneca plc (NYSE: AZN) has struck a new global development and commercialization agreement with Daiichi Sankyo Company (OTCMKTS: SKYF) that could be worth up to $6 billion. The agreement focuses on DS-1062, Daiichi Sankyo’s proprietary trophoblast cell-surface antigen 2 (TROP2)-directed antibody-drug conjugate (ADC), and potential new medicine for the treatment of multiple tumor types. AstraZeneca will pay $1 billion in staged payments over 24 months, and up to $5 billion for the successful achievement of regulatory approvals and sales-related milestones. The companies will jointly develop and commercialize DS-1062 worldwide, except in Japan where Daiichi Sankyo will maintain... Read More »
Benefytt Technologies Gets New PE Investment
Madison Dearborn Partners, the Chicago-based private equity firm, isn’t a major investor in the healthcare market, especially compared with some other firms, but it did announce a new acquisition in July. The private equity firm purchased Benefytt Technologies, Inc. (NASDAQ: BFYT) for $420.7 million. Madison Dearborn paid $31 cash per share (13.57 million shares), a 59% premium over the 30-day volume-weighted average price per share of Benefytt’s common stock through the close of trading on July 10, 2020. Benefytt Technologies develops and operates private e-commerce health insurance marketplaces, purchaser engagement platforms, agency technology systems and insurance policy... Read More »
Health Care M&A Deals, July 17, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week was Genentech, Inc.’s collaboration on pralsetinib with Blueprint Medicines Corporation valued at $775 million. Blueprint Medicines and Genentech will co-commercialize pralsetinib and equally share profits in the U.S. Roche will obtain an exclusive license to commercialize pralsetinib outside the U.S., excluding Greater China. To subscribe to our... Read More »
Banner Health Goes On an Acquisition Spree
Banner Health, the Phoenix, Arizona-based not-for-profit health system, is bucking a trend. Thanks to the impact of the COVID-19 epidemic in the United States, some healthcare analysts expect 2020 will be a “throw-away year” for earnings and M&A activity. Not so for Banner Health, which owns and operates 28 acute-care hospitals in six states, as well as Banner Health Network, Banner University Medicine, academic and employed physician groups, long-term care centers, outpatient surgery centers and an array of other services. It reported revenue of $2.37 billion in the first quarter of 2020, up from $2.33 billion in the same period in 2019. In August 2019, the system acquired... Read More »
Medicrea Acquired by Medtronic to Boost Spinal Surgery Portfolio
Medtronic plc (NYSE: MDT) has had a busy 2020, but the global device manufacturer doesn’t seem to be slowing down. On June 15, the company announced it acquired Medicrea (OTCMKTS: MRNTF) for $158.7 million, or $8 a share. This acquisition will strengthen Medtronic’s position as a global innovator in enabling technologies and solutions for spine surgery. Medicrea leads the design, integrated manufacture, and distribution of more than 30 510(k) cleared implant technologies, utilized in over 175,000 spinal surgeries to date. It has 175 employees worldwide, including 35 employees in New York City. The company also has a modern manufacturing facility in Lyon, France, housing the... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
